Loading...
* - Tentative Dates
The Company intends to utilise the Net Proceeds from the Issue towards funding of the following objects:
Astec Lifesciences Limited's revenue decreased by 17% and profit after tax (PAT) dropped by 187% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 |
| Revenue | 381.30 | 458.18 |
| Profit After Tax | -134.71 | -46.89 |
| Net Worth | 234.75 | 369.29 |
| Reserves and Surplus | 215.13 | 349.68 |
| Amount in ₹ Crore | ||
Astec Lifesciences manufactures active ingredients and intermediates for agrochemical and pharmaceutical segments. It is a contract development and manufacturing (CDMO) player, offering herbicides and fungicides products.
The company has 9 chemical manufacturing units in Maharashtra.